Loading…

Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications

Several flavonoids have been recognized as nutraceuticals, and myricetin is a good example. Myricetin is commonly found in plants and their antimicrobial and antioxidant activities is well demonstrated. One of its beneficial biological effects is the neuroprotective activity, showing preclinical act...

Full description

Saved in:
Bibliographic Details
Published in:BMC complementary and alternative medicine 2020-08, Vol.20 (1), p.241-14, Article 241
Main Authors: Taheri, Yasaman, Suleria, Hafiz Ansar Rasul, Martins, Natália, Sytar, Oksana, Beyatli, Ahmet, Yeskaliyeva, Balakyz, Seitimova, Gulnaz, Salehi, Bahare, Semwal, Prabhakar, Painuli, Sakshi, Kumar, Anuj, Azzini, Elena, Martorell, Miquel, Setzer, William N, Maroyi, Alfred, Sharifi-Rad, Javad
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Several flavonoids have been recognized as nutraceuticals, and myricetin is a good example. Myricetin is commonly found in plants and their antimicrobial and antioxidant activities is well demonstrated. One of its beneficial biological effects is the neuroprotective activity, showing preclinical activities on Alzheimer, Parkinson, and Huntington diseases, and even in amyotrophic lateral sclerosis. Also, myricetin has revealed other biological activities, among them as antidiabetic, anticancer, immunomodulatory, cardiovascular, analgesic and antihypertensive. However, few clinical trials have been performed using myricetin as nutraceutical. Thus, this review provides new insights on myricetin preclinical pharmacological activities, and role in selected clinical trials.
ISSN:2662-7671
2662-7671
1472-6882
DOI:10.1186/s12906-020-03033-z